Boundless Life

Held Hostage: How The FDA Is Keeping You From Using Your Own Stem Cells (& What You Can Do About It)

Aug 8, 2019
Dr. Tami Meraglia, a double board-certified MD and CEO of Global Stemology, discusses the recent FDA rulings that restrict the use of your own fat-derived stem cells in the U.S. She shares insights on how this impacts personal health autonomy and compares the U.S. approach to more progressive countries. The conversation covers the intersection of diet, emotional health, and stem cell therapy, while exploring innovative treatments and the importance of legal advocacy for patient access to regenerative medicine.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ANECDOTE

Dr. Meraglia's Father's COPD

  • Dr. Meraglia's father had COPD, a lung disease with no known cure.
  • After stem cell treatment and lifestyle changes, he significantly reduced his oxygen dependence.
INSIGHT

FDA's Stem Cell Ruling

  • The FDA classifies stem cells from your own fat as a drug, requiring expensive pharmaceutical processing.
  • This makes autologous stem cell treatments inaccessible while other countries approve them.
ADVICE

Stem Cell Alternatives

  • Consider bone marrow, umbilical, amniotic, or placental stem cells as alternatives to fat-derived stem cells.
  • Each stem cell source has unique benefits, and one size doesn't fit all.
Get the Snipd Podcast app to discover more snips from this episode
Get the app